Scott G. Ginn - 16 Feb 2024 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
EVP, CFO & COO
Signature
Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
16 Feb 2024
Net transactions value
-$301,494
Form type
4
Filing time
21 Feb 2024, 21:01:49 UTC
Previous filing
28 Jun 2023
Next filing
28 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +16,553 +24% $0.000000 86,395 16 Feb 2024 Direct F1, F2
transaction AMED Common Stock Tax liability $301,494 -3,218 -3.7% $93.69 83,177 20 Feb 2024 Direct F2
holding AMED Common Stock 2,714 16 Feb 2024 Through 401(k) Plan F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 16,553 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
F3 The information in this report is based on a plan statement dated as of December 31, 2023.